...
首页> 外文期刊>Journal of Photochemistry and Photobiology, B. Biology: Official Journal of the European Society for Photobiology >In vitro toxicity testing of zinc tetrasulfophthalocyanines in fibroblast and keratinocyte cells for the treatment of melanoma cancer by photodynamic therapy
【24h】

In vitro toxicity testing of zinc tetrasulfophthalocyanines in fibroblast and keratinocyte cells for the treatment of melanoma cancer by photodynamic therapy

机译:光动力疗法对四硫代酞菁锌在成纤维细胞和角质形成细胞中治疗黑素瘤癌症的体外毒性测试

获取原文
获取原文并翻译 | 示例

摘要

A series of water-soluble tetrasulfonated metallophthalocyanines (MPcs) dyes have been studied to be used as a drug or photosensitizer (PS) in photodynamic therapy (PDT) for the treatment of cancers. During PDT the PS is administrated intravenously or topically to the patient before laser light at an appropriate wavelength is applied to the cancerous area to activate the PS. The activated PS will react with oxygen typically present in the cancerous tissue to generate reactive oxygen species for the destruction of the cancerous tissue. This in vitro study aimed at investigating the cytotoxic effects of different concentrations of zinc tetrasulfophthalocyanines (ZnTSPc) activated with a diode laser ( λ = 672 nm) on melanoma, keratinocyte and fibroblast cells. To perform this study 3 x 10~4 cells/ml were seeded in 24-well plates and allowed to attach overnight, after which cells were treated with different concentrations of ZnTSPc. After 2 h, cells were irradiated with a constant light dose of 4.5 J/cm~2. Post-irradiated cells were incubated for 24 h before cell viability was measured using the CellTiter-Blue Viability Assay. Data indicated high concentrations of ZnTSPc (60-100 μg/ml) in its inactive state are cytotoxic to the melanoma cancer cells. Also, results showed that photoactivated ZnTSPc (50 μg/ml) was able to reduce the cell viability of melanoma, fibroblast and keratinocyte cells to 61%, 81% and 83% respectively. At this photosensitizing concentration the efficacy the treatment light dose of 4.5 J/cm~2 against other light doses of 2.5 J/cm~2, 7.5 J/cm~2 and 10 J/cm~2 on the different cell lines were analyzed. ZnTSPc at a concentration of 50 ug/ml activated with a light dose of 4.5 J/cm~2 was the most efficient for the killing of melanoma cancer cells with reduced killing effects on healthy normal skin cells in comparison to the other treatment light doses. Melanoma cancer cells after PDT with a photosensitizing concentration of 50 μg/ml and a treatment light dose of 4.5 J/cm~2 showed certain apoptosis characteristics such as chromatin condensation and fragmentation of the nucleus. This concludes that low concentrations of ZnTSPc activated with the appropriate light dose can be used to induce cell death in melanoma cells with the occurrence of minimal damage to surrounding healthy tissue.
机译:研究了一系列水溶性四磺化金属酞菁(MPcs)染料,它们被用作光动力疗法(PDT)中的药物或光敏剂(PS),用于治疗癌症。在PDT期间,在将适当波长的激光应用于癌变区域以激活PS之前,先对患者静脉内或局部施用PS。活化的PS将与通常存在于癌组织中的氧发生反应,从而产生活性氧,从而破坏癌组织。这项体外研究旨在研究用二极管激光器(λ= 672 nm)活化的不同浓度的四硫代酞菁锌(ZnTSPc)对黑素瘤,角质形成细胞和成纤维细胞的细胞毒性作用。为了进行这项研究,将3 x 10〜4个细胞/ ml接种到24孔板中,使其附着过夜,然后用不同浓度的ZnTSPc处理细胞。 2小时后,以4.5J / cm 2的恒定光剂量照射细胞。辐照后的细胞孵育24小时,然后使用CellTiter-Blue Viability Assay测定细胞活力。数据表明,处于非活性状态的高浓度ZnTSPc(60-100μg/ ml)对黑素瘤癌细胞具有细胞毒性。此外,结果表明,光活化的ZnTSPc(50μg/ ml)能够将黑色素瘤,成纤维细胞和角质形成细胞的细胞活力分别降低至61%,81%和83%。在该光敏浓度下,分析了在不同细胞系上4.5 J / cm〜2的治疗光剂量相对于2.5 J / cm〜2、7.5 J / cm〜2和10 J / cm〜2的其他光剂量的功效。与其他治疗光剂量相比,以4.5 J / cm〜2的光剂量活化的浓度为50 ug / ml的ZnTSPc最有效地杀死黑素瘤癌细胞,对健康正常皮肤细胞的杀伤作用降低。 PDT后光敏浓度为50μg/ ml,治疗光剂量为4.5 J / cm〜2的黑素瘤癌细胞具有一定的凋亡特性,例如染色质浓缩和细胞核碎裂。这得出结论,以适当的光剂量激活的低浓度ZnTSPc可用于诱导黑素瘤细胞死亡,并且对周围健康组织的损害最小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号